NSE filing, NSE: ANGELONE. Summary written from the filing by ALFA Finder's alert engine.
Angel One Ltd: key numbers
- Share price
- ₹282.25
- Market cap
- ₹25,814 Cr
- Revenue (annual)
- ₹5,137 Cr
- Net profit (annual)
- ₹915.1 Cr
- P/E (TTM)
- 22.3×Sector 19.8×
- Promoter holding
- 28.55%-0.04% QoQ
- FII holding
- 12.51%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Angel One Ltd
All →Angel One Employee Stock Options
Angel One allotted 5,24,942 equity shares to eligible employees under its Long Term Incentive Plan 2021. Paid-up capital now stands at ₹91.51 Crore.
Angel One Legal & Regulatory
Angel One gave board comments on an NSE fine for delayed LODR compliance. The delay was deemed inadvertent; the fine has been paid.
Angel One Results Update
Angel One Limited released its Q2 FY27 business and financial performance highlights. The report covers standalone and consolidated revenue, EBDAT, and key operational metrics.
Angel One Investor Presentation: Key Takeaways
Angel One delivered strong Q2 FY27 performance with consolidated PAT reaching ₹3.35 Bn, growing 58.2% YoY. The company continues to evolve into a multi-product financial ecosystem using AI-led engagement.
Angel One Other Announcement
Angel One Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI Listing Regulations for the quarter ended September 30, 2026.
Angel One Employee Stock Options
Angel One Limited has granted 20,598 Restricted Stock Units to an eligible employee under its Employee Long Term Incentive Plan 2021.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.